B-Cell CLL/lymphoma 2 (BCL2) (N-Term) Peptid
BCL2
Reaktivität: Human
Wirt: Synthetic
BP, BI
Kurzübersicht für B-Cell CLL/lymphoma 2 (BCL2) (N-Term) Peptid (ABIN5686032)
Target
Bcl-2 (BCL2)
(B-Cell CLL/lymphoma 2 (BCL2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), BioImaging (BI)
-
-
Protein Region
- N-Term
-
Produktmerkmale
- BCL2 peptide corresponds to 16 amino acids near the N-terminus region of BCL2.
-
-
B-Cell CLL/lymphoma 2 (BCL2) peptide
BCL2 Reaktivität: Human, Maus, Ratte, Hund Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- BCL2 Peptide is used for blocking the activity of BCL2 antibody . The BCL2 antibody ships at 0.5 mg/mL and the BCL2 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- BCL2 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
-
Sie sind hier:
